Patent 7060808 was granted and assigned to ImClone Systems on June, 2006 by the United States Patent and Trademark Office.
A nucleic acid is provided which encodes a humanized antibody or fragment thereof, which encodes a protein which binds to human EGF-receptor. Monoclonal antibody 225 is the complementary determining region (CDR) donor.